A Future
Within Reach
Pioneering treatments
for 15q13.3
Reed's Reach is committed to accelerating research and bringing transformative treatments to everyone affected by 15q13.3 microdeletion and associated conditions including epilepsy and autism spectrum disorder.
Reaching out to community
Our research
We fund a multi-pronged therapeutic pipeline, from repurposed drugs to pioneering ASO and gene therapies, to address the root genetic causes of 15q13.3 and related conditions.
Our Community
We foster a collaborative ecosystem of patients, families, researchers, and clinicians to align on strategic priorities and provide a trusted source of information.
Driving Broader Impact
Our work provides a direct pathway to understanding and treating more prevalent conditions like autism, schizophrenia, and bipolar disorder. We believe that studying rare, multi-gene syndromes like 15q13.3 can uncover insights that will be transformative for millions.
For us, By us.
My name is Reed. Living with 15q13.3 microdeletion syndrome means my world is a little different. I have Autism Spectrum Disorder and epilepsy, and it’s harder for me to do some things. I know other kids with 15q13.3 can have even bigger challenges than me. But my hope for the future is big. My family helped me start Reed’s Reach for 15q13.3 because I want to reach out and help every person and family affected by this condition.
This is more than a mission; it's my voice, and our promise, to fight for a better future.
Stay Informed. Join Our Community.
Receive updates on our research progress, clinical trial milestones, and community news.